Artem

About Artem Andrianov, Ph.D., MBA

Professional in the integration of data-driven Risk-based Quality Management (RBQM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, Health 2.0, DGGF, etc. 18+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RBQM research to new frontiers for CROs, pharma and biotech companies.
Jun 2015

Analytics Start-Up Brings Innovation To Clinical Trials (Article in BusinessBecause)

By |2016-11-16T18:35:45+02:00June 2, 2015|News|0 Comments

An article written by Seb Murray using his specific business-friendly and concise style about Cyntegrity and its founders: "The evolution of clinical trials, with increases in globalization, study complexity and technological capabilities, means there is a need to bring innovative approaches to drug development. Artem Andrianov, a [...]

Go to Top